Nayya Announces Referral Agreement with Mercer to Introduce Nayya to Employers across the United States
NEW YORK, March 26, 2025 /PRNewswire/ -- Nayya today announced that it is working with Mercer to introduce its cutting-edge...
Disability
Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect
SAN DIEGO, and GREENWOOD, S.C., March 24, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) and Greenwood Genetic Center (GGC)...
Brainomix Completes £14M ($18M) Series C Round to Advance Its Transformative AI Imaging Technology in Healthcare
University of Oxford spinout accelerates commercial expansion in the US of its innovative stroke AI imaging solution, with its demonstrated...
EvolutionIQ’s AI-Powered Specialist Intervention Optimizes Workers’ Compensation Claims Management
NEW YORK, March 19, 2025 /PRNewswire/ -- EvolutionIQ, a leader in AI-driven claims solutions, has announced the findings of its...
UNLOCKING INDEPENDENCE: KENCREST AND REPRESENTATIVE JOE CIRESI ADVOCATE FOR LIFTING PENNSYLVANIA’S ASSISTIVE TECHNOLOGY CAP
KenCrest's Smart Home Tour Highlights How Funding Limits Restrict Access to Life-Changing Technology BLUE BELL, Pa., March 19, 2025 /PRNewswire/...
Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation
Collaboration aims to make portable MRI faster, smarter, and more accessible worldwide. GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking...
Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation
Collaboration aims to make portable MRI faster, smarter, and more accessible worldwide. GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking...
Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis
Nes-Ziona, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...
Waterdrop Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results and a Cash Dividend
BEIJING, March 12, 2025 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated...
Lindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDD
BOSTON, March 11, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science...
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering
The in-demand program provides high-touch, holistic support for working parents and caregivers, addressing return-to-work challenges, emotional health support, and benefit...
Kaerus Bioscience Successfully Completes Phase 1 Trial and Demonstrates Proof of Mechanism with its Novel BK Channel Modulator KER-0193 being developed for Fragile X Syndrome
LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Kaerus Bioscience (www.kaerusbio.com), a clinical-stage biopharmaceutical company created by Medicxi for the development...
BARUCH COLLEGE: NOTICE OF SECURITY INCIDENT
NEW YORK, March 6, 2025 /PRNewswire/ -- Baruch College ("Baruch"), a public college in New York City, is providing notice of...
CENTER FOR THE HELPING PROFESSIONS LAUNCHES
Nashville, TN-based NonProfit Focused on Improving Systems Through Safety Science and Evidence-Based Approaches NASHVILLE, Tenn., March 6, 2025 /PRNewswire/ -- The...
HyBryte™ Treatment Studies Presented at Two Medical Conferences in March
Two Presentations Highlight Data Demonstrating Hypericin Photodynamic Therapy Potential with a Preliminary Comparison to Current Therapy PRINCETON, N.J., March 6,...
Sun Life is named a strategic Workday Wellness partner to make benefits easier for employers through enhanced data connectivity
WELLESLEY, Mass., March 5, 2025 /PRNewswire/ -- Sun Life U.S., a leading provider of employee benefits and human resource technology solutions,...
KENCREST BOARD NAMES AURORA KRIPA ITS NEXT CEO
She will replace President and CEO Marian Baldini who will be retiring in December BLUE BELL, Pa., March 3, 2025...
Enlivex Announces Positive Interim Data – Statistically Significant 47.0% Durable and Persistent Pain Reduction At Six Months, in Patients with Moderate to Severe Knee Osteoarthritis
Nes-Ziona, Israel, March 03, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...
NKGen Biotech Announces Administration of First Dose of Troculeucel to Stroke Patient Under FDA-Cleared Compassionate Use Program
NKGen explores the use of troculeucel as a potential treatment option for post-stroke patients.SANTA ANA, Calif., March 03, 2025 (GLOBE...
Praxis Precision Medicines Provides Update on Essential3 and Corporate Update
BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...